Lucas Van Bortel#

Membership Number:7619
Membership type:ORDINARY
Section:BASIC AND CLINICAL TRANSLATIONAL SCIENCES
Elected:2026
Main Country of Residence:BELGIUM
Homepage(s):
Publication Link:


Present and Previous Positions
  • 2021 - ongoing Chairman of the College Clinical Trials appointed by the Minister of Health Belgium
  • 2012 - 2014 President of the ARTERY Society
  • 2009 - 2018 visiting professor in PHARMED course, Free University of Brussels (ULB), Belgium
  • 2008 - 2010 President of the Belgian Hypertension Committee
  • 2007 - 2011 Chairman of the working group on arterial structure and function of the European Society of Hypertension
  • 2003 - 2007 member of the Ethics Committee of Ghent University Hospital, Belgium
  • 2001 - 2015 Founder and Head of Drug Research Unit Ghent, the early phase drug research unit, Ghent University Hospital, BE
  • 2000 - 2015 Professor Clinical Pharmacology and Pharmacotherapy, Faculty of Medicine, Ghent University, Belgium
  • 1989 - 2000 head of division of clinical pharmacology, dept of pharmacology, Maastricht University, The Netherlands
  • 1985 - 1993 internist - fellow clinical Pharmacology, Maastricht University, The Netherlands

Fields of Scholarship
  • Hypertension
  • Early drug development
  • Large artery stiffness, with focus on making noninvasive methods ready for use in clinical practice
  • Rational pharmacotherapy
  • Noninvasive measurement of central and peripheral blood pressure

Honours and Awards
  • 2021 Honorary member of Healixia, Belgian community of professionals active along the life cycle of medicines
  • 2016 Honorary member of the Dutch Society of Clinical Pharmacology and Biopharmacy
  • 2016 Lifetime achievement lecture invited by the Dutch Society of Clinical Pharmacology and Biopharmacy
  • 2016 - 2019 member of the Euphemed extended board (European Federation for Exploratory Medicines Development)
  • 2016 Artery Lifetime Achievement Award
  • 2014 Honorary member of the Artery Society
  • 2013 Invited member of AERES evaluation mission: INSERM U970 Paris-Cardiovascular research center (PARCC)
  • 2011 Invited member of AERES evaluation mission: INSERM research center Rouen
  • 2010 - 2014 member of the board of the Belgian Hypertension Committee
  • 2010 - 2015 member of the board of the Belgian Association of Phase I Units (BAPU)
  • 2007 - ongoing member of the editorial board of Artery Research
  • 2006 10th AstraZeneca award of the Belgian Hypertension Committee. Award for the best research group on hypertension.
  • 2006 - 2010 member of the editorial board of the Journal of Hypertension
  • 2006 - 2014 Founding member and board member of the Artery Society
  • 2004 European Hypertension Specialist (recognised by the European Society of Hypertension (ESH))
  • 2003 - ongoing Elected member of the Belgian Center for Pharmaceutical Information
  • 2000 - 2007 Member of the Council of the European Association for Clinical Pharmacology (EACPT)
  • 1998 - 2010 member of the board of ENOTT (European Network of Therapeutic Teachers)
  • 1996 - 1999 member of the editorial board of the Journal of Hypertension
  • 1995 - 2010 member of the executive board of The Dutch Society of Clinical Pharmacology and Biopharmacy


Imprint Privacy policy « This page (revision-6) was last changed on Wednesday, 27. May 2026, 13:30 by System
  • operated by